InventisBio Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Public

  • Employees
  • 182

Employees

  • Stock Symbol
  • 688382

Stock Symbol

  • Share Price
  • $1.98
  • (As of Friday Closing)

InventisBio General Information

Description

InventisBio Co Ltd is engaged in Research, development, production and sales of inventive drugs.

Contact Information

Website
www.inventisbio.cn
Formerly Known As
Shanghai YeYan Technology Co., Ltd.
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Number 63, Lane 1000
  • Zhangheng Road, Pudong New District
  • Shanghai
  • China
+86 021
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Stock Exchange
SHG
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Number 63, Lane 1000
  • Zhangheng Road, Pudong New District
  • Shanghai
  • China
+86 021

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

InventisBio Stock Performance

As of 13-Nov-2026, InventisBio’s stock price is $1.98. Its current market cap is $1.15B with 580M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.98 $2.08 $1.78 - $4.96 $1.15B 580M 15M -$0.10

InventisBio Financials Summary

As of 30-Sep-2026, InventisBio has a trailing 12-month revenue of $10.3M.

In Thousands,
USD 		TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 1,453,570 2,035,371 831,666 946,449
Revenue 10,309 5,185 23,523 26,223
EBITDA (56,616) (45,362) (34,928) (42,316)
Net Income (55,021) (44,062) (33,476) (40,139)
Total Assets 212,911 243,521 263,122 305,035
Total Debt 2,609 3,154 3,277 1,639
Public Fundamental Data provided by Morningstar, Inc. disclaimer

InventisBio Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore InventisBio‘s full profile, request access.

Request a free trial

InventisBio Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion
Price		 % Owned

This information is available in the PitchBook Platform. To explore InventisBio‘s full profile, request access.

Request a free trial

InventisBio Patents

  • 3

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

InventisBio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2017217536-A1 Inhibitor of indoleamine-2,3-dioxygenase (ido) Inactive 09-Feb-2016
WO-2017139414-A1 Inhibitor of indoleamine-2,3-dioxygenase (ido) Inactive 09-Feb-2016
WO-2017136688-A1 Selective estrogen receptor degraders and uses thereof Inactive 05-Feb-2016 C07D495/04

InventisBio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

InventisBio Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore InventisBio‘s full profile, request access.

Request a free trial

InventisBio ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

45.25 | Severe Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,585

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Biotechnology

Subindustry

of 431

Rank

Percentile

To view InventisBio’s complete esg history, request access »

InventisBio FAQs

  • When was InventisBio founded?

    InventisBio was founded in 2013.

  • Where is InventisBio headquartered?

    InventisBio is headquartered in Shanghai, China.

  • What is the size of InventisBio?

    InventisBio has 182 total employees.

  • What industry is InventisBio in?

    InventisBio’s primary industry is Biotechnology.

  • Is InventisBio a private or public company?

    InventisBio is a Public company.

  • What is InventisBio’s stock symbol?

    The ticker symbol for InventisBio is 688382.

  • What is the current stock price of InventisBio?

    As of 13-Nov-2026 the stock price of InventisBio is $1.98.

  • What is the current market cap of InventisBio?

    The current market capitalization of InventisBio is $1.15B.

  • What is InventisBio’s current revenue?

    The trailing twelve month revenue for InventisBio is $10.3M.

  • What is InventisBio’s annual earnings per share (EPS)?

    InventisBio’s EPS for 12 months was -$0.10.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process